Modern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults with depression, anxiety, trauma, and other mental health conditions. The program offers five days a week of clinician-led telehealth treatment, providing a middle ground between weekly therapy and inpatient care. Available in seven states with in-network coverage from major insurers including Blue Cross Blue Shield, Aetna, Cigna, and Optum/United.

The Global Initiative on Loneliness and Connection (GILC) is hosting the Global Connection Forum on June 17, 2026, to address social disconnection as a major public health and economic challenge. The forum will bring together leaders from public health, policy, and philanthropy to explore how social connection can repair polarization and division. Research shows chronic disconnection increases illness risk by 26-28% and costs employers $159 billion annually in lost productivity.

Cigna reported Q1 2026 adjusted earnings of $7.79 per share, beating consensus of $7.61, with sales rising 5% to $68.52 billion. The company raised its full-year adjusted EPS outlook to at least $30.35. However, Cigna announced plans to exit the individual exchange business by year-end and initiated a strategic review of eviCore. CEO David Cordani will transition to Executive Chair, with Brian Ivanko becoming CEO in July 2026.

The Cigna Group's Board of Directors declared a quarterly cash dividend of $1.56 per share, payable on June 18, 2026, to shareholders of record as of June 4, 2026.

Boone Capital Management liquidated its entire $13.57 million stake in Cogent Biosciences (945,042 shares) in Q4 2026, despite the stock surging 372% over the past year. The fund reallocated capital to earlier-stage biotech opportunities like TYRA, which has gained 40% in 2026, suggesting a strategic shift toward higher-risk, higher-upside clinical-stage investments.

Ushur announced Voice-Guided Experience, a new capability that enables organizations in regulated industries to guide customers through complex workflows using synchronized voice and mobile interactions. The AI-powered feature keeps voice conversations active while opening a synchronized mobile experience, allowing customers to speak or tap without switching channels. The platform supports 74 languages, maintains enterprise-grade compliance (HITRUST r2, SOC 2, HIPAA), and is designed to improve completion rates and reduce operational burden for healthcare, insurance, and financial services organizations.

The global dental insurance market is projected to grow from USD 118.77 billion in 2026 to USD 198.31 billion by 2032, with a CAGR of 8.72%. Growth is driven by digital transformation, evolving care models, and regulatory shifts. Key trends include provider consolidation, value-based care models, and increased investment in analytics and digital-first distribution channels.

In recent earnings releases, KKR reported strong revenue of $5.74B (beating $2.11B expectations) but missed on EPS at $1.12 vs $1.14 expected. Cummins exceeded revenue expectations at $8.5B but fell short on EPS at $4.27 vs $5.01 expected due to Electrolyzer business charges. The Cigna Group outperformed on both metrics with $72.47B revenue and $8.08 EPS, demonstrating strong operational discipline.

The FTC finalized a settlement with Cigna's Express Scripts pharmacy benefit manager to reduce anticompetitive practices and lower insulin costs by up to $7 billion over the next decade. Cigna reported strong Q4 2025 earnings, beating revenue and EPS estimates, and increased its quarterly dividend to $1.56 per share. The stock rose 3.53% following the announcement.

The FTC has secured a landmark settlement with Cigna's Express Scripts requiring elimination of spread pricing, decoupling rebates from drug list prices, relocating its GPO from Switzerland to the U.S., and adopting a cost-plus reimbursement model for independent pharmacies starting in 2027. The NCPA views this as a major victory against anticompetitive PBM practices that have artificially inflated drug prices and harmed independent pharmacies.

The FTC has paused its administrative case against major pharmacy benefit managers (PBMs) including Cigna, CVS Health, and UnitedHealth Group, suggesting settlement negotiations may be underway. The 14-day suspension delays the evidentiary hearing to July 1. The case, filed in September 2024, accuses PBMs of unfair practices that inflated insulin prices. Recent investigations and political pressure from the Trump administration have intensified scrutiny on PBM practices, particularly regarding markups on specialty drugs and alleged use of shell companies to obscure profits.

UnitedHealth Group CEO Stephen Hemsley testified before House panels that rising hospital prices, consolidation, and prescription drug costs—not insurers—are the primary drivers of U.S. health care spending. He pledged to voluntarily eliminate and rebate profits on ACA exchange coverage this year and urged policy reforms including site-neutral payments and patent reform. UnitedHealth also announced a pilot program to accelerate Medicare Advantage payments for rural hospitals.